Epithelial Tumors of the Thymus Book

1	Classification of Thymic Epithelial Neoplasms	1
2	Thymic Carcinoma	9
3	Thymoma/Thymic Carcinoma: A Distinctive, Unusual Morphologic Entity	17
4	A Clinicopathological Study of Thymomas in Singapore	23
5	Thymoma: A Clinicopathologic Study of 60 Cases	29
6	p53-Alterations in Thymic Epithelial Tumors	35
7	p53 Protein Expression on Thymic Epithelial Tumors	41
8	p53 Overexpression and Thymoma Prognosis	47
9	Metallothionein Expression in Thymomas: A Tumor Marker for Spindle and Squamoid Thymoma Cells	55
10	Cytokeratin (CK) Profile in Thymomas: CK 10 Is a Marker for Cortical Thymomas and CK 20 a Marker for Medullary Thymomas	57
11	Neuroendocrine Differentiation in Thymic Epithelial Tumors: Immunohistochemical Studies	67
12	Microscopic Thymoma and Myasthenia Gravis: A Clinicopathological and Immunohistochemical Study of Two Cases	75
13	Complex and Differential Cytokeratin Profiles in Thymomas and Correlation with Normal Thymus	81
14	Unusual Recurrence of Mixed Thymoma in Breast	91
15	Histiocytosis-X of the Thymus: Development of Myelomonocytic Leukemia 5 Years after Thymectomy	95
16	T Cell Development in the Human Thymus	105
17	Intrathymic Autoantigens and Their Role in the Shaping of the Autoimmune T Lymphocyte Repertoire	111
18	T Cell Epitopes of the Acetylcholine Receptor and the Pathogenesis of Myasthenia Gravis	119
19	Thymus in Thymoma-Associated Myasthenia Gravis: Transplantation of Thymoma and Extrathymomal Thymic Tissue into SCID Mice	127
20	Thymic Tumor Progression in SV40T Transgenic Mice Model: Suggestion of Thymoma Thymic Carcinoma Sequence	135
21	Analysis of a Murine Thymic Carcinogenesis Model Induced by the Expression of Large T of SV40	155
22	Inefficient Positive Selection of CD4+ T Cells in Epithelial Cell Tumors of the Human Thymus	157
23	Abnormal T Lymphocyte Development in Myasthenia Gravis-Associated Thymomas	165
24	Oligoclonal Peripheral T-Cell Lymphocytosis as a Result of Aberrant T-Cell Development in a Cortical Thymoma	179
25	Estogens Modulate IL-6 Production by Cultured Normal and Pathological Human Thymic Epithelial Cells	187
26	Thymoma and Autoimmune Neurological Disorders: A Search for Missing Links in Pathogenesis	195
27	T-Cell Derived Mechanisms in the Pathogenesis of Myasthenia Gravis	205
28	Thymomas Express Ryanodine Receptor Epitopes	213
29	Titin Epitope in Thymoma	221
30	Accessory Molecule Expression in Human Thymomas and Thymus	229
31	CD40-Expression in Thymoma	235
32	Myasthenia Gravis with Thymoma and Fas Antigen	247
33	Myasthenia Gravis Patients Have a Cellular Immune Response against Titin	253
34	Tumor Necrosis Factor Gene Polymorphisms in Thymoma and Non-Thymoma Myasthenia Gravis	261
35	Clinical Immunology of Thymic Tumors in Patients with Myasthenia Gravis	265
36	Myasthenia Gravis with Thymoma	271
37	Reproducibility of a Histogenetic Classification of Thymic Epithelial Tumours	281
38	Morphology of Thymic Remnants Removed after Video-Assisted Thoracoscopic Extended Thymectomy in Patients with Thymomatous Myasthenia Gravis	289
39	Core Needle Biopsy of Anterior Mediastinum Masses	293
40	Cyclin-Dependent Kinase 6 (PLSTIRE) Expression in Normal Thymus, Thymomas, and T-Cell Lymphoblastic Lymphoma	299
41	Our Approach in the Preparation for Thymectomy in Myasthenia Gravis	305
42	Onset of Myasthenia Gravis after Thymectomy for Thymoma	315
43	Aspects of Clinical Preparation of Thymectomy in Myasthenic Cases with or without Thymoma and the Clinico-Biological Follow-up of the Thymectomized Patients	319
44	Long-Term Prognosis of Patients with Thymoma-Associated Myasthenia Gravis	329
45	Thymoma and Myasthenia Gravis: Incidence of Tumor Recurrences in 126 Patients	337
46	Thymoma - Prognostic Factors and Outcome	343
47	Management of Thymectomised Myasthenic Patients	351
48	Management of Thymectomized Myasthenic Patients	357
49	Therapeutic Options in Locally Advanced Thymoma	365
50	The Role of Radiotherapy in Treatment of Thymoma	371
	Authors and Sponsors	381
	Index	383